Desire Takou

Desire Takou

Auto-generated profile, based on publicly available information

Desire Takou

Chantal Biya International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2023 in African Journal of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
RKRachel S. Kamgaing
Rachel S. Kamgaing
YBYagai Bouba
Yagai Bouba
SSSamuel Martin Sosso
Samuel Martin Sosso
JGJeremiah E. Gabisa
Jeremiah E. Gabisa
ANAubin Nanfack
Aubin Nanfack
ANAlexis Ndjolo
Alexis Ndjolo
Introduction: Determining the HIV status of some individuals remains challenging due to multidimensional factors such as flaws in diagnostic systems, technological challenges, and viral diversity. This report pinpoints challenges faced by the HIV testing system in Cameroon. Case presentation: A 53-year-old male received a positive HIV result by a rapid testing algorithm in July 2016. Not convinced of his HIV status, he requested additional tests. In February 2017, he received a positive result using ImmunoComb® II HIV 1 & 2 BiSpot and Roche cobas electrochemiluminescence assays. A sample sent to France in April 2017 was positive on the Bio-Rad GenScreen™ HIV 1/2, but serotyping was indeterminate, and viral load was < 20 copies/mL. The Roche electrochemiluminescence immunoassay and INNO-LIA HIV I/II Score were negative for samples collected in 2018. A sample collected in July 2019 and tested with VIDAS® HIV Duo Ultra enzyme-linked fluorescent assay and Geenius™ HIV 1/2 Confirmatory Assay was positive, but negative with Western blot; CD4 count was 1380 cells/mm3 and HIV proviral DNA tested in France was ‘target-not-detected’. Some rapid tests were still positive in 2020 and 2021. Serotyping remained indeterminate, and viral load was ‘target-not-detected’. There were no self-reported exposure to HIV risk factors, and his wife was HIV-seronegative. Management and outcome: Given that the patient remained asymptomatic with no evidence of viral replication, no antiretroviral therapy was initiated. Conclusion: This case highlights the struggles faced by some individuals in confirming their HIV status and the need to update existing technologies and develop an algorithm for managing exceptional cases.

9 March 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
CTCarine Tadenfok
Carine Tadenfok
JFJoseph Fokam
Joseph Fokam
ESEzechiel Ngoufack Jagni Semengue
Ezechiel Ngoufack Jagni Semengue
LMLeonella Mossiang
Leonella Mossiang
SOSteve Oyie
Steve Oyie
CNCéline Nguefeu Nkenfou
Céline Nguefeu Nkenfou
HIV treatment has significantly improved with the introduction of potent antiretroviral therapy (ART), particularly dolutegravir (DTG)-based regimens. With

9 July 2026 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
CTCarine Tadenfok
Carine Tadenfok
JFJoseph Fokam
Joseph Fokam
ESEzechiel Ngoufack Jagni Semengue
Ezechiel Ngoufack Jagni Semengue
AOAntoine Silvère Olongo
Antoine Silvère Olongo
GFGuy Fako
Guy Fako
CNCéline Nguefeu Nkenfou
Céline Nguefeu Nkenfou
Men having sex with men (MSM) in Cameroon are disproportionately affected by HIV. We evaluated virological response and HIV drug resistance (HIVDR) at a co

1 January 2026 in Journal of Public Health in Africa
Verified
Journal Article
Open access
PDF file
MTMichel Carlos TOMMO TCHOUAKET
Michel Carlos TOMMO TCHOUAKET
JFJoseph Fokam
Joseph Fokam
ESEzechiel Ngoufack Jagni Semengue
Ezechiel Ngoufack Jagni Semengue
YBYagai Bouba
Yagai Bouba
CACollins Chenwi Ambe
Collins Chenwi Ambe
ANAlexis Ndjolo
Alexis Ndjolo
Background: Nasopharyngeal swabs (NASO) cause discomfort for patients, which can discourage them from getting tested for COVID-19 and limit case detection. It is therefore necessary to consider an alternative, more comfortable swab. Aim: Evaluated the concordance between nasopharyngeal and oropharyngeal sampling for COVID-19 diagnosis in the Cameroonian context. Setting: This study was carried out at “Chantal Biya” International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB) in Yaoundé, Cameroon. Methods: A comparative study was conducted in April 2021 among consenting participants tested for COVID-19 at “Chantal Biya” International Reference Centre for Research on HIV/AIDS Prevention and Management (CIRCB) in Yaoundé, Cameroon. Sampling began with nasopharyngeal swabs, followed by oropharyngeal swabs, all taken by the same technician, and analysis was carried out using polymerase chain reaction (PCR) tests on the Abbott platform. Statistical analyses were performed using GraphPad version 6.0; p < 0.05 was considered statistically significant. Results: A total of 154 participants were enrolled (59.7% male, median age 38 years, interquartile range [IQR]: 30–49). Following PCR testing, the overall COVID-19 positivity rate was 36.36% (56/154), with 34.41% (n = 53/154) in nasopharyngeal versus 16.23% (n = 25/154) in oropharyngeal samples, p < 0.0002. The overall concordance rate was 78% (n = 120/154), with 39.28% positive concordance and 74.24% negative concordance (kappa = 0.441 [0.289–0.513]). According to severe acute respiratory syndrome coronavirus 2 viral load, the positive concordance was improved with high viral load (cycle threshold [CT]: ≤ 25): 61% (n = 11/18) versus 31% (n = 11/35) with low viral load (CT > 25), p = 0.037; odds ratio (OR) = 3.43. According to gender, the positive concordance was higher in men, 55% (n = 16/29), versus 25% (n = 6/24) in women, p = 0.021; OR = 0.27. Using nasopharyngeal swab as the gold standard, oropharyngeal swab had a sensitivity of 41.50% (n = 22/53), specificity 97.02% (n = 98/101), positive predictive value (PPV) 88% (n = 22/25) and negative predictive value (NPV) 76% (n = 98/129). Conclusion: Our evidence suggests a superiority effect of nasopharyngeal in detecting cases of COVID-19. However, the overall high PPV of oropharyngeal swab, and its improved performance with high viral load. Contribution: Therefore, in case of counter-indication to nasopharyngeal swabbing, oropharyngeal can be an acceptable alternative.

1 January 2025 in Journal of Public Health in Africa
Verified
Journal Article
Open access
PDF file
JFJoseph Fokam
Joseph Fokam
CACyrille Alain Abega Abega
Cyrille Alain Abega Abega
ESEzechiel Ngoufack Jagni Semengue
Ezechiel Ngoufack Jagni Semengue
AAAissatou Abba
Aissatou Abba
DTDésiré Takou
Désiré Takou
ANAlexis Ndjolo
Alexis Ndjolo
Optimised supplies management for an efficient response in a context of a pandemic in Cameroon. Background: Response strategy against COVID-19 relies on adequate materials and consumables supply. Aim: As a national reference COVID-19 laboratory in Cameroon, the Chantal BIYA International Reference Center (CIRCB) has evaluated the consumption of materials and consumables supply for PCR, variant screening and sequencing, in view of better prediction of the needs. Setting: Chantal Biya International Reference Centre for research on human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) prevention and management (CIRCB), Yaoundé-Cameroon. Methods: This was a descriptive cross-sectional study conducted between August 2021 and July 2022 which focused on stock supply evaluation through analysis of data from services performed at CIRCB, Cameroon. The weighted averages method was used in statistics. Results: Overall, 31 453 samples were received, 37 008 extractions and 37 248 PCRs were performed for COVID-19 diagnosis, representing an average monthly consumption of 3084 extractions and 3104 PCRs for ~2621 samples/month (~1.17 extractions/sample and ~1.18 PCRs/sample). Of the 2238 (7.1%) positive cases diagnosed, 265 were processed for variants’ screening and 200 to sequencing due to their high cycle threshold (CT < 25). In screening, 288 tests were used, i.e. 1.08 tests/sample. For sequencing, 279 tests were used, i.e. 1.39 tests/sample. Conclusion: The estimates obtained reveal a precise quantification of the supplies used for diagnosis, variant screening and sequencing during a season of high COVID-19 epidemics at CIRCB-Cameroon. Contribution: Adequate implementation of this logistical strategy would optimize supply management and help to save associated costs while ensuring effective genomic surveillance or response when faced with any public health incident in Cameroon.